Italy
Research Article
Baseline Analysis on the Outcome of Patients with Deep Vein Thrombosis (DVT) Before the Global Impact of New Oral Anticoagulants in Italy: Data from RIETE Registry
Author(s): Pierpaolo Di Micco, Adriana Visonà, Gianluca Di Micco, Anna Guida, David Jimenez, Paolo Prandoni, Iolanda Enea, Alferio Niglio, Laurent Bertoletti and Manuel MonrealPierpaolo Di Micco, Adriana Visonà, Gianluca Di Micco, Anna Guida, David Jimenez, Paolo Prandoni, Iolanda Enea, Alferio Niglio, Laurent Bertoletti and Manuel Monreal
Background: In patients with venous thromboembolism (VTE), assessment of the risk of recurrent VTE and major bleeding may help to guide intensity and duration of anticoagulant therapy. Methods: We used the Registro Informatizado de Enfermedad Tromboemb?lica (RIETE) to identify predictors of poor adherence to guidelines in patients with- and without cancer, and to assess the rate and severity of VTE recurrences and major bleeding during the course of anticoagulation in Italian patients with deep vein thrombosis (DVT). Results: A total of 3541 patients with objectively diagnosed VTE were enrolled in Italy, of whom 1832 (52%) initially presented DVT. Of these, 409 (22%) patients had already known cancer at baseline. In all, 32% of patients with cancer and 74% of those without cancer received long-term therapy with vitamin K antagonists, 55% and 19% respectively received long-term therapy.. Read More»
DOI:
10.4172/2165-7831.1000129
Journal of Blood & Lymph received 443 citations as per Google Scholar report